Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Formaldehyde Exposure Presents Unreasonable Risk to Humans: EPA More than one million Americans face an increased risk of leukemia, head and neck cancers from chronic formaldehyde exposure, according to the EPA. March 20, 2024 Katherine McDaniel Add Your Comments A preliminary report by federal environmental regulators has determined that formaldehyde exposure is unsafe for humans, potentially leading to asthma, allergic reactions, various forms of cancer and death. The U.S. Environmental Protection Agency (EPA) released the draft Formaldehyde Risk Evaluation on March 15, warning that a number of people routinely inhale or come into physical contact with formaldehyde, either from work in manufacturing fields or through the use of several common products, which may increase their risk of developing serious and potentially life-threatening health conditions. In the evaluation, the EPA assessed the many ways individuals are exposed to formaldehyde in both indoor and outdoor environments, as well as the associated health risks of short and long-term exposure. It found that workers face the highest risk of formaldehyde exposure, followed by consumers who frequently use certain products containing the chemical. Formaldehyde Health Risks Formaldehyde is an industrial chemical used to make many construction and building materials, paper products and cosmetics. However, exposure to high levels of the chemical can cause serious health problems when inhaled or absorbed through the skin. Short-term exposure to formaldehyde can cause eye irritation if inhaled or allergic reactions if it touches the skin, while longer exposure can result in lung damage, severe eye irritation, reproductive issues, asthma, allergy-related conditions, and even cancer. Formaldehyde exposure has been a concern among health experts for years, especially exposure from workplace environments and certain consumer products. Research published by the American Academy of Neurology in 2021 found that long-term formaldehyde exposure in the course of employment was associated with a 21% higher risk of cognitive impairment, including lower IQ scores and memory loss. In 2022, the EPA found that formaldehyde exposure from the use of industrial products may be associated with rare but serious cancers. The agency indicated that long-term exposure to even low formaldehyde levels could cause nasopharyngeal cancer, sinonasal cancer and myeloid leukemia, which impacts bone marrow and blood cells. As a result of the report, the U.S. Occupational Safety and Health Administration (OSHA) limited occupational formaldehyde exposure in the workplace to 0.75 ppm on average over an eight-hour workday, or 2 ppm not exceeding a 15-minute period. The U.S. Food and Drug Administration (FDA) proposed a ban on formaldehyde and chemicals that release formaldehyde from being used in hair relaxer and chemical hair straightener products in October 2023. Officials indicated use of those products was linked to sensitization reactions, breathing problems, and an increased risk of certain cancers. The FDA also recommended consumers avoid using products that contain the chemical. Formaldehyde Exposure Risks for Workers and Consumers The latest EPA report found that individuals exposed to formaldehyde at work, those who use products containing high concentrations of formaldehyde, people living or working near facilities that emit formaldehyde, and those living in mobile homes or other indoor environments with high formaldehyde concentrations face the highest exposure and health risks. According to the report, individuals who work with chemicals in the automotive and fuel product industries, including those who apply automotive lubricants, greases, fuels, paints, and spray products containing formaldehyde, are exposed to higher concentrations than in any other industry. Workers in or near facilities that manufacture and process chemical substances, such as paint additives, adhesives, sealants, and coatings, also have high exposure to formaldehyde. Industry workers inhale higher concentrations of the chemical after it is released into the air or by making skin contact with formaldehyde-containing materials, the agency determined. Products That May Expose Consumers to Formaldehyde The EPA also found some consumers also faced high formaldehyde exposure risks through many every day products, construction, and building materials. HAIR RELAXER COMPENSATION Did you or a loved one use hair relaxer products? Uterine cancer, endometrial cancer and ovarian cancer may be caused by chemicals in hair relaxer. See if you are eligible for benefits. Learn More SEE IF YOU QUALIFY FOR COMPENSATION HAIR RELAXER COMPENSATION Did you or a loved one use hair relaxer products? Uterine cancer, endometrial cancer and ovarian cancer may be caused by chemicals in hair relaxer. See if you are eligible for benefits. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Consumers are routinely exposed to formaldehyde through stone, plaster, cement, glass, ceramic, metal, and rubber products, wood furniture, paint, floor coverings, foam seating and bedding, cleaning and furniture care products. They also face an increased risk of suffering from adverse health effects with chronic formaldehyde exposure through adhesives, sealants, paint, coatings, art crafts, ink, toner, and other photographic supplies, the report indicated. Many individuals have chronic exposure to some levels of formaldehyde in the air, according to the EPA report. Processing facilities and industries that use combustible engines emit high concentrations of formaldehyde into the air, exposing anyone within 50 km. The EPA indicates that more than one million individuals face an increased risk of formaldehyde-induced leukemia and head and neck cancers due to chronic inhalation exposure. The EPA found that 15 minutes or more of formaldehyde exposure in a single day is associated with stomach problems and allergic reactions. Exposure over 5.5 hours for 250 days per year is associated with more severe gastrointestinal effects and allergic reactions, as well as breathing problems, reduced pulmonary function, allergies, and asthma. The agency concluded that long-term exposure to the chemical contributes to an increased risk of developing formaldehyde-induced cancers, including nasopharyngeal and leukemia cancers The findings will be available for a 60-day public comment period. A public meeting will be held on May 7, for the Science Advisory Committee on Chemicals (SACC) and public to submit questions before undergoing another virtual peer review public meeting, which will be held from May 20-23. Once the EPA receives comments and peer review inputs, it will revise and finalize a final risk evaluation assessment. For more information on the scheduled meetings, consumers may visit the SACC website. Tags: Asthma, Cancer, Chemicals, Formaldehyde, Hair Relaxer, Leukemia, Work Injury Find Out If You Qualify for Hair Relaxer Compensation More Hair Relaxer Lawsuit Stories Hair Relaxer Class Action Lawsuit Seeks Certification for Medical Monitoring Claims April 1, 2026 Hair Relaxer Endometrial Cancer Lawsuits and Ovarian Cancer Lawsuits Proposed for Early Trials March 23, 2026 Lawyers To Nominate Hair Relaxer Cancer Cases for Early Bellwether Trials Next Week March 12, 2026 0 Comments FacebookThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Medtronic SCS Lawsuit Alleges Intellis LT Neurostimulator Caused Worsening Pain (Posted: today) An Illinois woman has joined a growing number of plaintiffs alleging that the Medtronic Intellis neurostimulator, and similar devices, may fail to relieve chronic pain and instead lead to worsening complications. MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITNevro Spinal Cord Stimulator Lawsuits Filed Over Device Malfunction, Failure (03/30/2026)Abbott Proclaim SCS Lawsuit Alleges Stimulator Lead Migration Resulted in Multiple Surgeries (03/24/2026)Abbott, Boston Scientific Oppose Spinal Cord Stimulator Lawsuit MDL (03/20/2026) Court Outlines Plan To Prepare Suboxone Tooth Decay Lawsuits for Trial in Early 2028 (Posted: yesterday) Four Suboxone tooth decay lawsuits will eventually be selected and prepared for bellwether trials set to begin in March 2028, according to a court order. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITSuboxone Film Lawsuit Filed by 46 Users Alleging Drug Makers Ignored Years of Dental Injury Reports (03/03/2026)100 Suboxone Film Tooth Decay Lawsuits Selected for Next Phase of Bellwether Discovery (02/13/2026)Problems With Suboxone Dental Injury Records Collection Continues in MDL (01/26/2026) Hair Relaxer Class Action Lawsuit Seeks Certification for Medical Monitoring Claims (Posted: 2 days ago) A federal judge is being asked to certify seven hair relaxer class action lawsuits seeking medical monitoring for users, following studies that link the products to an increased risk of cancer. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Endometrial Cancer Lawsuits and Ovarian Cancer Lawsuits Proposed for Early Trials (03/23/2026)Lawyers To Nominate Hair Relaxer Cancer Cases for Early Bellwether Trials Next Week (03/12/2026)Court Outlines Procedures When Women Die After Filing a Hair Relaxer Cancer Lawsuit (02/25/2026)
Hair Relaxer Endometrial Cancer Lawsuits and Ovarian Cancer Lawsuits Proposed for Early Trials March 23, 2026
Medtronic SCS Lawsuit Alleges Intellis LT Neurostimulator Caused Worsening Pain (Posted: today) An Illinois woman has joined a growing number of plaintiffs alleging that the Medtronic Intellis neurostimulator, and similar devices, may fail to relieve chronic pain and instead lead to worsening complications. MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITNevro Spinal Cord Stimulator Lawsuits Filed Over Device Malfunction, Failure (03/30/2026)Abbott Proclaim SCS Lawsuit Alleges Stimulator Lead Migration Resulted in Multiple Surgeries (03/24/2026)Abbott, Boston Scientific Oppose Spinal Cord Stimulator Lawsuit MDL (03/20/2026)
Court Outlines Plan To Prepare Suboxone Tooth Decay Lawsuits for Trial in Early 2028 (Posted: yesterday) Four Suboxone tooth decay lawsuits will eventually be selected and prepared for bellwether trials set to begin in March 2028, according to a court order. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITSuboxone Film Lawsuit Filed by 46 Users Alleging Drug Makers Ignored Years of Dental Injury Reports (03/03/2026)100 Suboxone Film Tooth Decay Lawsuits Selected for Next Phase of Bellwether Discovery (02/13/2026)Problems With Suboxone Dental Injury Records Collection Continues in MDL (01/26/2026)
Hair Relaxer Class Action Lawsuit Seeks Certification for Medical Monitoring Claims (Posted: 2 days ago) A federal judge is being asked to certify seven hair relaxer class action lawsuits seeking medical monitoring for users, following studies that link the products to an increased risk of cancer. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Endometrial Cancer Lawsuits and Ovarian Cancer Lawsuits Proposed for Early Trials (03/23/2026)Lawyers To Nominate Hair Relaxer Cancer Cases for Early Bellwether Trials Next Week (03/12/2026)Court Outlines Procedures When Women Die After Filing a Hair Relaxer Cancer Lawsuit (02/25/2026)